Literature DB >> 9743315

Valuing outcomes in health care: a comparison of willingness to pay and quality-adjusted life-years.

M V Bala1, L L Wood, G A Zarkin, E C Norton, A Gafni, B O'Brien.   

Abstract

Quality-adjusted life-years (QALYs) and willingness to pay (WTP) are two preference-based measures of health-related outcomes. In this article, we compare these two measures in eliciting individuals' preferences for health outcomes associated with shingles. To collect the necessary preference data, we administered computer-interactive interviews to a sample of 65- to 70-year-olds. We found no significant correlation between QALYs and WTP across individuals. We discuss our findings and argue that our results raise questions about whether QALYs and WTP are equivalent preference-based measures of health outcomes.

Mesh:

Year:  1998        PMID: 9743315     DOI: 10.1016/s0895-4356(98)00036-5

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  20 in total

Review 1.  Willingness to pay as a measure of health benefits.

Authors:  M V Bala; J A Mauskopf; L L Wood
Journal:  Pharmacoeconomics       Date:  1999-01       Impact factor: 4.981

2.  QALYs: are they helpful to decision makers?

Authors:  Maurice McGregor; J Jaime Caro
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  Economic evaluation of a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in older adults in Switzerland.

Authors:  Thomas D Szucs; Reto W Kressig; Manto Papageorgiou; Werner Kempf; Jean-Pierre Michel; Anton Fendl; Xavier Bresse
Journal:  Hum Vaccin       Date:  2011-07-01

4.  The reliability and internal consistency of an Internet-capable computer program for measuring utilities.

Authors:  L A Lenert
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

5.  Putting your money where your mouth is: willingness to pay for dental gel.

Authors:  Debora Matthews; Angela Rocchi; Amiram Gafni
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

6.  Community and patient values for preventing herpes zoster.

Authors:  Tracy A Lieu; Ismael Ortega-Sanchez; G Thomas Ray; Donna Rusinak; W Katherine Yih; Peter W Choo; Irene Shui; Ken Kleinman; Rafael Harpaz; Lisa A Prosser
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

7.  A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK.

Authors:  Lee Moore; Vanessa Remy; Monique Martin; Maud Beillat; Alistair McGuire
Journal:  Cost Eff Resour Alloc       Date:  2010-04-30

8.  The duration effect: a link between TTO and VAS values.

Authors:  Benjamin M Craig
Journal:  Health Econ       Date:  2009-02       Impact factor: 3.046

9.  Assessing the Patient-Perceived Monetary Value of Patient-Reported Outcome Improvement for Patients With Chronic Knee Conditions.

Authors:  Sarah B Floyd; Alicia Oostdyk; Melanie Cozad; John M Brooks; Paul Siffri; Brian Burnikel
Journal:  J Patient Cent Res Rev       Date:  2021-04-19

10.  Increasing access to modern contraceptives: the potential role of community solidarity through altruistic contributions.

Authors:  Obinna E Onwujekwe; Chinwe Ogbonna; Nkoli Uguru; Benjamin S C Uzochukwu; Agathe Lawson; Bannet Ndyanabangi
Journal:  Int J Equity Health       Date:  2012-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.